Tentler et al. showed that SST receptor-2 inhibits adenylate cyclase and, consequently, cAMP production in pituitary tumor GH4C1 cells, which ultimately results in decreased protein kinase A (PKA) activity [46]. The gene discussed is ADCY1; the disease is pituitary tumor.